OFIX - Orthofix Medical Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Orthofix Medical Inc.
Orthofix International NV is a medical device company. It focuses on providing reconstructive and regenerative orthopedic and spine solutions to physicians.
IPO Date: April 24, 1992
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $366.59M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.48 | 1.56%
Avg Daily Range (30 D): $0.18 | 1.93%
Avg Daily Range (90 D): $0.26 | 2.50%
Institutional Daily Volume
Avg Daily Volume: .13M
Avg Daily Volume (30 D): .31M
Avg Daily Volume (90 D): .3M
Trade Size
Avg Trade Size (Sh.): 82
Avg Trade Size (Sh.) (30 D): 59
Avg Trade Size (Sh.) (90 D): 54
Institutional Trades
Total Institutional Trades: 2,735
Avg Institutional Trade: $1.31M
Avg Institutional Trade (30 D): $.81M
Avg Institutional Trade (90 D): $.9M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.18M
Avg Closing Trade (30 D): $.85M
Avg Closing Trade (90 D): $.92M
Avg Closing Volume: 49.73K
 
News
Mar 12, 2026 @ 7:45 AM
Orthobiologics Market to Surpass USD 9 Billion by ...
Source: Mordor Intelligence
Aug 6, 2025 @ 2:16 AM
Orthofix (OFIX) Q2 Revenue Rises 2%
Source: Jesterai
Apr 10, 2025 @ 5:30 AM
Intramedullary Nail Market size to worth USD 1,537...
Source: Coherent Market Insights
Feb 28, 2025 @ 3:56 PM
Prosthetic Disc Nucleus Market Outlook to Exceed U...
Source: Transparency Market Research Inc.
Nov 8, 2024 @ 9:00 PM
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.52 $-.39 $-.52
Diluted EPS $-1.52 $-.39 $-.52
Revenue $833.19M $210.93M $196.71M
Gross Profit $594.12M $149.71M $139.55M
Net Income / Loss $-61.72M $-15.8M $-20.91M
Operating Income / Loss $-39.12M $-8.13M $-14.44M
Cost of Revenue $239.07M $61.23M $57.16M
Net Cash Flow $35.98M $-16.42M $35.85M
PE Ratio